Clinical and experimental advances in treatment of visceral leishmaniasis
Clicks: 298
ID: 270358
2001
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
298 views
51 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #53 of 105 articles by views in Antimicrobial agents and chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Clinical and experimental advances in treatment of visceral leishmaniasis
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (9 words).
Try re-searching for a better abstract.
| Reference Key |
hw2001antimicrobialclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Murray HW;; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 2001 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
u.s. gov't
P.H.S.
immunotherapy
leishmaniasis
h w murray
visceral / drug therapy*
pmid:11451673
pmc90630
doi:10.1128/aac.45.8.2185-2197.2001
antiprotozoal agents / therapeutic use*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.